Overview

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

Status:
Completed
Trial end date:
2019-12-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether trabectedin is effective in the treatment of malignant pleural mesothelioma (MPM).
Phase:
Phase 2
Details
Lead Sponsor:
Mario Negri Institute for Pharmacological Research
Collaborator:
PharmaMar
Treatments:
Trabectedin